Genora 0.5/35 Interactions
There are 458 drugs known to interact with Genora 0.5/35 (ethinyl estradiol / norethindrone), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 52 are major, 359 are moderate, and 47 are minor.
- View all 458 medications that may interact with Genora 0.5/35
- View Genora 0.5/35 alcohol/food interactions (8)
- View Genora 0.5/35 disease interactions (24)
Most frequently checked interactions
View interaction reports for Genora 0.5 / 35 (ethinyl estradiol / norethindrone) and the medicines listed below.
- bisoprolol
- Diabetic Expectorant (guaifenesin)
- meropenem / vaborbactam
- Metadate CD (methylphenidate)
- Mononessa (ethinyl estradiol / norgestimate)
- omeprazole
- sars-cov-2 (covid-19) mrna-1273 vaccine
- Tornalate (bitolterol)
- Trexbrom (brompheniramine / chlophedianol / phenylephrine)
- Xultophy (insulin degludec / liraglutide)
Genora 0.5/35 alcohol/food interactions
There are 8 alcohol/food interactions with Genora 0.5 / 35 (ethinyl estradiol / norethindrone).
Genora 0.5/35 disease interactions
There are 24 disease interactions with Genora 0.5 / 35 (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Genora 0.5 / 35 (ethinyl estradiol / norethindrone)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.